Home/Filings/4/0000899243-21-009225
4//SEC Filing

Snyder Douglas B. 4

Accession 0000899243-21-009225

CIK 0001351288other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 9:42 PM ET

Size

20.4 KB

Accession

0000899243-21-009225

Insider Transaction Report

Form 4
Period: 2021-02-26
Snyder Douglas B.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2021-03-01$0.00/sh+6,636$973,656 total
  • Exercise/Conversion

    Share Options

    2021-02-26128,1720 total
    Exercise: $0.00From: 2021-02-26Exp: 2021-02-26Ordinary Shares (128,172 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2021-02-26$0.00/sh+9,612$1371,957 total
  • Tax Payment

    Ordinary Shares

    2021-02-26$17.90/sh65,827$1,178,30362,345 total
  • Tax Payment

    Ordinary Shares

    2021-02-26$17.90/sh4,937$88,37267,020 total
  • Exercise/Conversion

    Ordinary Shares

    2021-02-26$0.00/sh+128,172$179128,172 total
  • Tax Payment

    Ordinary Shares

    2021-03-01$17.85/sh3,408$60,83370,248 total
  • Exercise/Conversion

    Share Options

    2021-02-269,6120 total
    Exercise: $0.00From: 2021-02-26Exp: 2021-02-26Ordinary Shares (9,612 underlying)
  • Exercise/Conversion

    Share Options

    2021-03-016,6360 total
    Exercise: $0.00From: 2021-03-01Exp: 2021-03-01Ordinary Shares (6,636 underlying)
Footnotes (6)
  • [F1]Exercise of share options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  • [F2]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021.
  • [F3]Withhold to cover vested RSU style share options.
  • [F4]Represented by ADS.
  • [F5]The price reported is price per ordinary share converted from price per ADS.
  • [F6]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021.

Issuer

GW PHARMACEUTICALS PLC

CIK 0001351288

Entity typeother

Related Parties

1
  • filerCIK 0001754125

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:42 PM ET
Size
20.4 KB